TASE:KMDABiotechs
Kamada (TASE:KMDA) Margin Expansion To 11.7% Challenges Cautious Earnings Narratives
Kamada (TASE:KMDA) has just reported its FY 2025 third quarter numbers, posting revenue of US$47.0 million and basic EPS of US$0.09, supported by trailing 12 month revenue of US$174.8 million and EPS of about US$0.35. The company has seen quarterly revenue move from US$41.7 million in Q3 FY 2024 to US$47.0 million in Q3 FY 2025, alongside basic EPS holding around US$0.07 to US$0.09 over that period, while trailing net income reached US$20.4 million over the last 12 months. With net profit...